Pyruvate Kinase Differentially Alters Metabolic Signatures during Head and Neck Carcinogenesis

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Pyruvate kinase M2 (PKM2) is crucial for ATP production during glycolysis.
• PKM2 is often considered a tumor promoter in various cancers.
• The specific role of PKM2 in head and neck squamous cell carcinoma (HNSC) carcinogenesis requires further investigation.

Purpose of the Study:

• To investigate the expression and function of PKM2 in head and neck carcinogenesis.
• To determine the impact of PKM2 on HNSC malignancy, tumor growth, and treatment response.
• To elucidate the molecular mechanisms underlying PKM2's role in HNSC.

Main Methods:

• PKM2 mRNA and protein expression analysis in HNSC tissues.
• Functional studies using shRNA-mediated PKM2 knockdown in HNSC cell lines.
• In vivo xenograft tumor growth assays and cisplatin resistance assessments.
• Analysis of metabolic shifts and signaling pathway activation (Akt, ERK).

Main Results:

• PKM2 expression is elevated in HNSC tissues, but higher mRNA levels correlate with lower tumor stage and better survival.
• PKM2 deficiency leads to increased tumor growth and cisplatin resistance in vivo.
• PKM2 silencing reduces cell motility.
• Loss of PKM2 induces metabolic reprogramming towards mitochondrial metabolism and activates Akt/ERK signaling.

Conclusions:

• Contrary to its role in other cancers, PKM2 exhibits tumor-suppressive functions in HNSC.
• PKM2 modulates head and neck tumorigenicity through metabolic reprogramming and regulation of key signaling pathways.
• Targeting PKM2 or its downstream pathways could offer new therapeutic strategies for HNSC.